Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Mautner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of General Virology|August 19, 2007
The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon proteinDavid Onion, Laura J Crompton, Donald W Milligan, et al.
Blood|August 15, 2002
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recoverySuparno Chakrabarti, Vivien Mautner, Husam Osman, et al.
Human Gene Therapy|December 11, 2007
Gene therapy and cement injection for restabilization of loosened hip prosthesesJolanda J de Poorter, Rob C Hoeben, Simone Hogendoorn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in miceEmma L Davies, James D Ramsden, Helen Cocks, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Adenovirus type 5 interactions with human blood cells may compromise systemic deliveryMark Lyons, David Onion, Nicky K Green, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of General Virology|August 19, 2007
The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon proteinDavid Onion, Laura J Crompton, Donald W Milligan, et al.
Blood|August 15, 2002
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recoverySuparno Chakrabarti, Vivien Mautner, Husam Osman, et al.
Human Gene Therapy|December 11, 2007
Gene therapy and cement injection for restabilization of loosened hip prosthesesJolanda J de Poorter, Rob C Hoeben, Simone Hogendoorn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in miceEmma L Davies, James D Ramsden, Helen Cocks, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Adenovirus type 5 interactions with human blood cells may compromise systemic deliveryMark Lyons, David Onion, Nicky K Green, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Pageof 2